Beyond Pills and Needles: The Singapore Integrated Medicine 2025 Strategy
Explore the Singapore Integrated Medicine 2025 strategy as the government and private clinics fuse Traditional Chinese Medicine with Western approaches for an aging society.
Can ancient herbs and modern scalpels coexist? In Singapore, they aren't just coexisting—they're fusing. As of December 30, 2025, the city-state is aggressively scaling efforts to integrate Traditional Chinese Medicine (TCM) with Western clinical practices to tackle the challenges of an aging population.
Singapore Integrated Medicine 2025: A New Standard
Public and private sectors are joining forces to bridge the gap between these historically distinct fields. A prime example is the clinic jointly operated by Eu Yan Sang and Parkway Shenton. Here, practitioners like Chan Jing Wen see patients in an environment where diagnostic scans meet herbal prescriptions, creating a seamless patient journey.
The government's push for this hybrid model isn't just about cultural heritage; it's a pragmatic response to healthcare demands. By combining the precision of Western surgery with TCM's focus on holistic wellness, Singapore aims to enhance recovery rates and long-term health outcomes for seniors.
Bridging the Gap via Innovation
Traditional practitioners are increasingly working alongside Western-trained doctors. This synergy allows for a more comprehensive approach to chronic disease management, where lifestyle and dietary adjustments from TCM complement modern pharmaceutical interventions.
Authors
Related Articles
Samsung Electronics' union branch revealed that 84% of survey respondents oppose the government's roughly $290 billion (₩400 trillion) semiconductor megaproject in Gwangju. Government, management, the union and shareholders are all reading the same national project in sharply different ways.
Nvidia shipped roughly a billion RISC-V cores in 2024, then announced it would run CUDA on the open standard. We break down how royalty-free instruction sets and open software stacks are trying to route around CUDA's lock-in. Part 2 of the Semiconductor Sovereignty series.
US AI-chip export controls split into three layers in the first half of 2026 — January easing, a May crackdown on circumvention, and a pending bill. Nvidia erased China from its guidance and still posted a record $81.6 billion quarter. A look at the export policy that both shields and cages it.
AMD's MI325X matches or beats Nvidia on memory and bandwidth — yet Nvidia's 86-92% share holds. The real moat is CUDA, 20 years in the making. Part 1 of 4.
Thoughts
Share your thoughts on this article
Sign in to join the conversation